Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), filed a Form 4 on November 4, 2026, disclosing the sale of 3,419 shares of common stock on November 2, 2026, under two separate Rule 10b5-1 arrangements.
John Fesko, President and Chief Business Officer of Natera, Inc. (NASDAQ:NTRA), filed a Form 4 on November 4, 2026, disclosing the sale of 302 shares of common stock on November 2, 2026, to satisfy tax withholding obligations connected to the vesting of restricted stock …
Daniel Rabinowitz, Secretary and Chief Legal Officer of Natera, Inc., filed a Form 4 on November 4, 2026, disclosing the sale of 341 shares of common stock on November 2, 2026, to satisfy tax withholding obligations related to vesting restricted stock units.
Matthew Rabinowitz, Executive Chairman of Natera, Inc., filed a Form 4 on November 4, 2026, disclosing two sales of Natera common stock on November 2, 2026, executed under a Rule 10b5-1 plan to cover tax withholding obligations tied to RSU vesting.
Beth Ann Costello, EVP and CFO of Hartford Insurance Group, Inc., filed a Form 4 on November 4, 2026, disclosing the exercise of 31,597 stock options and the same-day sale of 31,597 shares of common stock on November 2, 2026, pursuant to a Rule …
Natera, Inc. co-founder and director Sheena Jonathan filed a Form 4 on November 4, 2026, disclosing the sale of 112 shares of common stock on November 2, 2026, to cover tax withholding obligations tied to vesting restricted stock units.
James R. Fenner, SVP and Chief Revenue Officer of Frontier Group Holdings, Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing his holdings as of an event date of October 27, 2026.
James Yanosy, Executive Vice President and Chief Risk Officer of Hartford Insurance Group, Inc., filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing holdings as of November 2, 2026.
Director Alex G. Howarth filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities held in Altimmune, Inc. as of the November 2, 2026 triggering event.
Armando Jose Cuello Navarro, Executive VP of Energy Transition at Ecopetrol S.A., filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing holdings as of the event date of October 27, 2026.